Friday, July 10, 2026

pharma · Epilepsy

Ucb Pharma S.P.A

Ucb Pharma S.P.A clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

ANDERLECHT, IT HQ
4 Employees
NMPA registrant Type
Company details
Status
Public
HQ
ANDERLECHT, IT
Employees
4
Programs
2
Drugs
3
Patents
0
Intelligence · Clinical Programs

Ucb Pharma S.P.A projects

2 ClinicalTrials.gov programs sponsored by Ucb Pharma S.P.A.

Ucb Pharma S.P.A has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Brivaracetam

    UCB Pharma

    Epilepsy

    phase 3 small molecule completed

    1 trial
  2. Levetiracetam

    UCB Pharma

    Epilepsy

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Ucb Pharma S.P.A have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.